Well that depends on their motivation. If its shareholder value they should roll their sleeves up... if its not I'd better question my investment again.
Hi all, maybe a dumb question, but whats Boohoo' s position on the FTSE if we find ourselves in auto promotion come Dec will we take it, or opt out like Asos and others?
Seems to be making steady progress up following the bottom, should continue to 290... then will get slower as it fills the gap to 300p. After that it'll probably depend on news, II's or Nov update. Personally hoping to see share buy back, as special Divi just attracts people to dip in and out, but buy back should reward LTH's.
Yes that’s an exciting prospect indeed and a niche space for us. Plus it can be used widely regardless of development of condition. I.e. I’m a bit paranoid and had close access to someone with Covid.... I better get a puff of SNG001.
Much better than I’m one of the low percentage that’s progressed to Ventilator, now give me Dexi, or other.
Ref link I had one that compared original submission and then amendments, check my history if interested.
Possibly, unless it’s like handing your homework in... only you know when your comfortable you’ve got good enough work to submit for the A grade your after. Maybe we’ve bounced it off a view consultants received the feedback and thought we don’t want a C when we know we can get an A, especially when it’s enough to get us on MAP in the meantime.
Just speculating like most on here but done my fair share of reading.
On going I don’t think the first ever stopped. When looking in various sources most show 400 subjects not 110 and one has finishe date of Feb 2021 other May 2021. These are just ones on hand on my mobile, I’ve seen others.
My view is that, we already know our current cohort is not significantly large enough or aligned enough with morbidity in placebo cohort. As such the additional arms were added, so they can broaden and confidently submit for approvals and peer review and then it’s a race to whichever comes first.
Doubt it, they are just averaging like we do, they dragged it down for a nice profit over 10p and generating some cash flow below 10p, either way I’m sure they are up overall.
RE: Germany "Compassionate Use" Programmes via AMHV1 Oct 2020 15:13
Hopefully it's going to snowball, and then create such volume pressures that authorities will have no choice but to fully endorse then facilitate a tri-party agreement to deliver at scale with a partner/acquisition.
RE: Germany "Compassionate Use" Programmes via AMHV1 Oct 2020 15:01
Hi Joey,
I assume you mean that when we get to step six, that we have an ongoing trial in UK which points to step 8, where the answer is no and therefore gets AMHV use approval.